MedTrace Logo

Ultrasound Screening for Developmental Dysplasia of the Hip in Newborns

NCT01818934 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11925

Last updated 2013-03-27

No results posted yet for this study

Summary

The aim of the randomized controlled trial was to determine whether the addition of a general or of a selective ultrasound screening program resulted in more appropriate criteria for treatment and a reduced prevalence of late DDH compared with clinical examination alone.

Conditions

  • Hip Dysplasia

Interventions

PROCEDURE

hip ultrasound

Standardized single-examiner Hip ultrasound was offered to all babies in the universal group, babies at increased risk in the selective group, and to no babies in the clinical exam only group

Sponsors & Collaborators

  • Institute of Child Health

    collaborator OTHER

  • University of Bergen

    lead OTHER

Principal Investigators

  • Karen Rosendahl, Prof · Pediatric section, Department of Radiology, Haukeland University hospital, University of Bergen

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1988-01-31
Primary Completion
1990-06-30
Completion
2009-03-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01818934 on ClinicalTrials.gov